Available via license: CC BY-NC-SA 3.0
Content may be subject to copyright.
© 2015 Journal of Pediatric Neurosciences | Published by Wolters Kluwer - Medknow / 331
Original Article
Diphtheritic polyneuropathy in the wake of
resurgence of diphtheria
D. Manikyamba, A. Satyavani, P. Deepa
Department of Pediatrics, Rangaraya Medical College, Kakinada, Andhra Pradesh, India
Address for correspondence: Dr. D. Manikyamba, Department of Pediatrics, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
E‑mail: manirmurthy@gmail.com
ABSTRACT
Objective: To study the clinical profile and outcome in children with diphtheritic polyneuropathy (DP).
Methodology: 13 children with polyneuropathy were included in this study. Their demographic profile, age, sex
and immunization status were recorded. Detailed clinical and neurological examination was done. Investigations
like CSF analysis, NCV studies, MRI brain were done. The results were tabulated and analyzed. Results: All
the children presented with bulbar palsy and had h/o membranous tonsillitis. Isolated palatal palsy was seen
in 7 children (53%). 6 (46.1%) children developed quadriparesis. 1 child expired and recovery is complete in
rest of the 12 children. Children with isolated bulbar palsy recovered within 2 to 4 weeks while children with
quadriparesis recovered within 5‑6 wks. Conclusions: Any child diagnosed with diphtheria should be followed
for 3‑6 months in anticipation of neurological complications. DP carries good prognosis hence timely diagnosis
and differentiation from other neuropathies is a prerequisite for rational management.
Key words: Anti‑diphtheritic serum, complications, diphtheria, polyneuropathy
Introduction
Diphtheritic polyneuropathy (DP) is recognized as one of the
most severe complications of diphtheria, caused by exotoxin of
Corynebacterium diphtheriae. Among 20,000 cases of diphtheria
reported by WHO during 2007–2011, 17,926 (89.6%) cases
were from India alone.[1] Most persons with diphtheria in India
are either partially immunized or unimmunized.
Scarce reports of DP in the Indian literature may result from
under-recognition and perhaps, under-reporting of this entity.
In this paper, we present a case series of 13 children with DP
from South India admitted in our hospital from July 2013 to
December 2013.
During the same period, 19 children admitted with membranous
tonsillitis in our hospital were identified as probable or
confirmed cases of diphtheria with culture positivity in
13 children. They were treated with anti-diphtheritic
serum (ADS) and antibiotics. Among 19 children, 7 children
expired and the rest were followed for 6 months.
The simultaneous resurgence of clinical diphtheria in our area
helped us probe into the history of those children who presented
with neuropathy and throw light on this latent entity which is
almost forgotten by the present day physicians and neurologists.
In India, apart from the case series from Delhi, there is no other
case series reported so far in the recent past.
Methods
Thirteen children with DP were included in this study. Their
Cite this article as: Manikyamba D, Satyavani A, Deepa P. Diphtheritic
polyneuropathy in the wake of resurgence of diphtheria. J Pediatr Neurosci
2015;10:331-4.
This is an open access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows
others to remix, tweak, and build upon the work non-commercially, as long as the
author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
Access this article online
Quick Response Code:
Website:
www.pediatricneurosciences.com
DOI:
10.4103/1817-1745.174441
[Downloaded free from http://www.pediatricneurosciences.com on Wednesday, September 28, 2016, IP: 91.248.105.162]
Manikyamba, et al.: Diphtheritic polyneuropathy
332 / Journal of Pediatric Neurosciences / Volume 10 / Oct-Dec / 2015
demographic profile, age, sex, and immunization status were
recorded. Detailed clinical and neurological examination
was done. Investigations such as cerebrospinal fluid (CSF)
analysis, nerve conduction velocity (NCV) studies, Magnetic
resonance imaging (MRI) brain were carried out. The
results were tabulated and analyzed. Among 13 children,
10 presented with neuropathy whose past histories revealed
membranous tonsillitis. Three children presented to us with
respiratory diphtheria and developed neuropathy during
follow-up.
Results
Children in the present series were in the age group of
5–13 years. All the children had history of membranous
tonsillitis with a latency period of 15–40 days between the
onset of tonsillitis and neurological symptoms.
All 13 children had bulbar palsy. Isolated palatal palsy was
seen in 7 children (53%). Oculomotor nerve involvement in
the form of accommodation paralysis was seen in 3 children.
One child had unilateral lower motor neuron facial palsy and
6 children developed quadriparesis after palatal palsy, which
was descending and symmetric in nature [Table 1].
Supportive treatment with Ryle’s tube feeding was given to
all children for 1–4 weeks.
One child expired during hospital stay due to aspiration.
Recovery was complete in rest of the 12 children.
Children with isolated bulbar palsy recovered within 2–4 weeks
while children with quadriparesis recovered within 5–6 weeks.
Discussion
The incidence of neurologic complications is related directly
to the severity of respiratory symptoms. DP is seen in 20% and
75% of patients with mild and severe infection, respectively.[2]
Table 1: Details of children with DP
Age/sex Immunization
status*
Central nervous system ndings Course of the disease after
membranous tonsillitis
Investigations: CSF‡, NCV§, MRI||
13/female Unimmunized Hypotonia,areexia,power‑3/5
Cranial nerve palsies: 3rd, 7th, 9th, 10th
3rd week-bulbar palsy
4th week-quadriparesis
16th week-recovery of speech
20th week-recovery of weakness
CSF: Protein elevation
NCV: Axonal degeneration
MRI: Normal
11/female Unimmunized Hypotonia,areexia,power‑3/5
Cranial nerve palsies: 9th, 10th
4th week-nephrosis, myocarditis
5th week-bulbar palsy
6th week-quadriparesis
8th week-recovery of speech
12th week-recovery of weakness
CSF: Protein elevation
NCV: Axonal degeneration
MRI: Normal
9/female†Partially
immunized
Hypotonia,areexia,power‑3/5
Cranial nerve palsies: 3rd, 6th, 9th,
10th
3rd week-bulbar palsy, blurred
vision, diplopia
4th week-quadriparesis
6th week-expired
CSF: Protein elevation
NCV: Axonal degeneration
MRI: Normal
8/female Unimmunized Hypotonia,areexia,power‑3/5
Cranial nerve palsies: 9th, 10th
5th week-bulbar palsy
7th week-quadriparesis
10th week-recovery of speech
12th week-recovery of weakness
CSF: Protein elevation
NCV: Axonal degeneration
MRI: Normal
9/female Unimmunized Hypotonia,areexia,power‑3/5
Cranial nerve palsies: 9th, 10th
2nd week-bulbar palsy
4th week-recovery
CSF: Protein elevation
NCV: Demyelinating variety
MRI: Normal
11/female Partially
immunized
Hypotonia,reexes+,power‑4/5
Cranial nerve palsies: 9th, 10th
4th week-bulbar palsy
7th week-recovery
Not done
9/male Partially
immunized
Normaltone,reexes+,power‑5/5
cranial nerve palsies: 9th, 10th
3rd week-bulbar palsy
7th week-recovery
Not done
12/female Unimmunized Normaltone,reexes+,power‑5/5
Cranial nerve palsies: 9th, 10th
4th week-bulbar palsy
7th week-recovery
Not done
5/female Partially
immunized
Normaltone,reexes+,power‑5/5
Cranial nerve palsies: 9th, 10th
5th week-bulbar palsy
10th week-recovery
Not done
11/male Partially
immunized
Normaltone,areexia,power‑5/5
Cranial nerve palsies: 9th, 10th
6th week-bulbar palsy
10th week-recovery
CSF: Protein elevation not seen
NCV and MRI not done
10/male Unimmunized Normaltone,areexia,power‑5/5
Cranial nerve palsies: 9th, 10th
5th week-bulbar palsy
8th week-recovery
Not done
9/female Partially
immunized
Normaltone,areexia,power‑5/5
Cranial nerve palsies: 9th, 10th
7th week-bulbar palsy
10th week-recovery
Not done
8/male Unimmunized Normaltone,areexia,power‑5/5
Cranial nerve palsies: 9th, 10th
6th week-bulbar palsy
10th week-recovery
Not done
*6 (47%) children were partially immunized and 7 (53%) children were unimmunized, †C diphtheriae was isolated from throat swab culture in this child, ‡CSF analysis revealed
albumino-cytological dissociation in 4 patients, §NCV showed axonal degeneration in 4 children and demyelination in 2 children with quadriparesis, ||MRI brain and spine was done in
childrenwithquadriparesisanditwasnormalinallofthem.DP:Diphtheriticpolyneuropathy,MRI:Magneticresonanceimaging,NCV:Nerveconductionvelocity,CSF:Cerebrospinaluid
[Downloaded free from http://www.pediatricneurosciences.com on Wednesday, September 28, 2016, IP: 91.248.105.162]
Manikyamba, et al.: Diphtheritic polyneuropathy
2015 / Oct-Dec / Volume 10 / Journal of Pediatric Neurosciences / 333
The period between the appearance of first symptom of
diphtheria and the development of DP is termed latency,
which varies from 10 days to 3 months.[3] The first indication
of neuropathy is paralysis of the soft palate and posterior
pharyngeal wall.[4] Bulbar dysfunction typically develops
during the first 2 weeks. Oculomotor and ciliary paralyses
seen after 3 weeks are common and distinctive features of DP.
Peripheral neuritis develops later, from 10 days to 3 months
after the onset of oropharyngeal disease. In some patients,
there may be a secondary worsening of the bulbar symptoms
along with the occurrence of peripheral neuropathy.[2]
Biphasic course of disease was noted only in 2 children in our
study which is contradictory to other studies.
Various studies on major epidemic outbreaks from Russia and
Europe in the past gave us valuable insights on pathophysiology
and progression of DP. Diptheritic toxin penetrates into
Schwann cells and it inhibits the synthesis of myelin
proteolipid and basic protein.[4] It was observed in vitro that it
binds to Schwann cells as early as 1-hr postinjection, inducing
the latent development of polyneuropathy.[5] This stresses the
importance of immediate administration of ADS. Local toxic
effects occur by direct spread of toxin and result in the early
bulbar problems while the ensuing generalized demyelinating
neuropathy arises from hematogenous dissemination.[6] The
reason behind isolated palatal palsy in few children with no
systemic involvement is probably nondissemination of the
toxin.
DP has to be distinguished from other neuropathies especially
Guillain–Barre syndrome (GBS) which is more common in
children. The clinical features differentiating DP from GBS
are high prevalence of bulbar palsy, slower evolution of the
neuropathy for more than 4 weeks, descending nature, and
simultaneous involvement of other organ systems. NCV
studies and CSF findings are similar to those in GBS. The
management and prognosis of DP differs from GBS.[7]
Profile of DP in various studies is described in Table 2. In
2005, Logina and Donaghy reported an attenuated form
of neuropathy in the immunized population of Latvia. This
was attributed to the protective effects of the vaccine, which
attenuated the adverse effects of exotoxin. Compared to the
previous epidemic in 1999, the incidence and severity were
lower in same area due to early diagnosis and administration
of ADS within first 3 days of disease.[8] With this review of
literature and supportive evidence from our study, we stress
upon the recognition of epidemic in its incipient stage and
prompt administration of ADS.
Studies from Russia showed a significant trend of decreasing
immunity with increasing age, resulting in lack of protection,
particularly for adults aged 30 to 50 years. As vaccine
induced immunity wanes over time, periodic boosters are
recommended every 10 years. Thus the susceptibility of adults
to diphtheria is a new phenomenon of the vaccine era.[9]
In India, Mohanta and Parija reported 86 cases of DP in
children from Odisha in 1974.[10] Mild respiratory muscle
involvement was seen in one child in our study in contrast to
the study by Sandeep Kumar et al.(2010) from Delhi where
respiratory muscles were involved in 85.4% cases and 60.4%
required mechanical ventilation.[11] In 2013, Mateen et al.
reported a case series of 15 children with DP from nine
states and Union territories, detected through Acute flaccid
paralysis (AFP) surveillance [2002–2008]. Their study
demonstrates that DP can be detected through existing AFP
surveillance system.
Conclusions
Pediatricians/neurophysicians should have a high index of
suspicion to recognize DP in the wake of recent resurgence of
diphtheria in some parts of India. Any child diagnosed with
probable diphtheria should be followed for 3–6 months for
neurological complications.
As seen in our case series, DP carries good prognosis hence
timely diagnosis and differentiation from other neuropathies
is a prerequisite for rational management and contact
tracing.
Continued occurrence of diphtheria emphasizes the need for
public health measures such as:
Table 2: Features of DP in various studies
Our study AFP surveillance Delhi (2010) Latvia (1997) Latvia (2005)
Age group 5-13 <15 4.25 41-60 18-24
Immunization status
Complete 80%
Partial 47% 15%
Unimmunized 53% 100% 5%
Latency in days 15-30 10 10 43
Isolated palatal palsy 60% 15% 6% 10% 0
Limb involvement 40% 85% 94% 90% 100%
CSF analysis 80% protein elevation
20%-normal
100%-normal 100%-normal
Mechanical ventilation No 20% 60% No
Recovery (in days) 21-102 days 20-115 30
Fatal outcome 8% 46% 14.6% 16% 0
DP:Diphtheriticpolyneuropathy,AFP:Acuteaccidparalysis
[Downloaded free from http://www.pediatricneurosciences.com on Wednesday, September 28, 2016, IP: 91.248.105.162]
Manikyamba, et al.: Diphtheritic polyneuropathy
334 / Journal of Pediatric Neurosciences / Volume 10 / Oct-Dec / 2015
• Strengtheningofroutineimmunizationandmandatory
booster vaccination at school entry and Td booster[12] at
10 years intervals thereafter
• Vaccinationofsusceptiblecontactsandprophylactic
antibiotics to contacts
• EnsuringavailabilityofADSfortimelyadministration
and thereby preventing complications
• AFPsurveillancesystemcanbeutilizedtoidentifyDP
and thus areas of resurgence of diphtheria and strengthen
immunization services in those pockets.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
1. Mateen FJ, Bahl S, Khera A, Sutter RW. Detection of diphtheritic
polyneuropathy by acute flaccid paralysis surveillance, India. Emerg
Infect Dis 2013;19:1368-73.
2. Hadfield TL, McEvoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The
pathology of diphtheria. J Infect Dis 2000;181 Suppl 1:S116-20.
3. Piradov MA, Pirogov VN, Popova LM, Avdunina IA. Diphtheritic
polyneuropathy: Clinical analysis of severe forms. Arch Neurol
2001;58:1438-42.
4. McAuley JH, Fearnley J, Laurence A, Ball JA. Diphtheritic
polyneuropathy. J Neurol Neurosurg Psychiatry 1999;67:825-6.
5. Pleasure DE, Feldmann B, Prockop DJ. Diphtheria toxin inhibits the
synthesis of myelin proteolipid and basic proteins by peripheral nerve
in vitro. J Neurochem 1973;20:81-90.
6. Solders G, Nennesmo I, Persson A. Diphtheritic neuropathy, an analysis
based on muscle and nerve biopsy and repeated neurophysiological
and autonomic function tests. J Neurol Neurosurg Psychiatry
1989;52:876-80.
7. Logina I, Donaghy M. Diphtheritic polyneuropathy: A clinical study
and comparison with Guillain-Barré syndrome. J Neurol Neurosurg
Psychiatry 1999;67:433-8.
8. Krumina A, Logina I, Donaghy M, Rozentale B, Kravale I, Griskevica A,
et al. Diphtheria with polyneuropathy in a closed community despite
receiving recent booster vaccination. J Neurol Neurosurg Psychiatry
2005;76:1555-7.
9. Hann AF. Resurgence of diphtheria in the newly independent states
of the former Soviet Union: A reminder of risk. J Neurol Neurosurg
Psychiatry 1999;67:426.
10. Mohanta KD, Parija AC. Neurological complications of diphtheria.
Indian J Pediatr 1974;41:237-43.
11. Kanwal SK, Yadav D, Chhapola V, Kumar V. Post-diphtheritic
neuropathy: A clinical study in paediatric intensive care unit of a
developing country. Trop Doct 2012;42:195-7.
12. World Health Organization. Diphtheria: Immunization Surveillance,
Assessment, and Monitoring. Available from: http://www.who.int/
immunization_monitoring/diseases/diphteria/en/index.html.[Last cited
on 2013 Mar 05].
Staying in touch with the journal
1) Table of Contents (TOC) email alert
Receive an email alert containing the TOC when a new complete issue of the journal is made available online. To register for TOC alerts go to
www.pediatricneurosciences.com/signup.asp.
2) RSS feeds
Really Simple Syndication (RSS) helps you to get alerts on new publication right on your desktop without going to the journal’s website.
You need a software (e.g. RSSReader, Feed Demon, FeedReader, My Yahoo!, NewsGator and NewzCrawler) to get advantage of this tool.
RSS feeds can also be read through FireFox or Microsoft Outlook 2007. Once any of these small (and mostly free) software is installed, add
www.pediatricneurosciences.com/rssfeed.asp as one of the feeds.
[Downloaded free from http://www.pediatricneurosciences.com on Wednesday, September 28, 2016, IP: 91.248.105.162]